⌘K

Login Start Free

Home/Filings/4/0001615774-18-010441

4//SEC Filing

Thomas Steffen 4

Accession 0001615774-18-010441

CIK 0001314052other

View on SEC.gov Company Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 5:30 PM ET

Size

5.4 KB

Accession

0001615774-18-010441

Insider Transaction Report

Form 4

Period: 2018-10-01

ANAVEX LIFE SCIENCES CORP.AVXL

Director

Transactions

Award
Stock Option (Right to Buy)
2018-10-01+45,500→ 45,500 total
Exercise: $2.58Exp: 2028-10-01→ Common Stock (45,500 underlying)

Footnotes (1)

[F1]The options shall vest upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials.

Documents

1 file

4
s113105_form4.xmlPrimary
FORM 4

Issuer

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052

Entity typeother

Related Parties

1

filerCIK 0001646396

Filing Metadata

Form type: 4
Filed: Oct 2, 8:00 PM ET
Accepted: Oct 3, 5:30 PM ET
Size: 5.4 KB

View on SEC.gov